National Symposium on Drug Repurposing for Future Pandemics
17-18th November 2020
Virtual Symposium
The Symposium
Two Days of Visionary Talks
17-18th November 2020
11 am - 5 pm EST
Pandemics demand safe and effective therapies developed and deployed at an unprecedented speed. This Symposium, organized on behalf of the National Science Foundation (NSF), provides a forum for scientists and researchers from a variety of fields relevant to therapeutics. Participants discuss ways to expedite the development of therapies by compressing years of work into months or even weeks through automation, artificial intelligence and machine learning, novel data sources, and most recent biotechnology advancements.
The Symposium brings together leading experts in computer science, biology, statistics, medicine, automation, and regulation. While these areas of expertise are necessary for rapid therapeutic innovation, there is seldom an opportunity for these experts to interact with each other.
Bearing in mind new opportunities and pressing challenges, the Symposium provides a roadmap and puts forward recommendations on transforming today’s tools into ready-to-use solutions to fight future pathogens.
Social Media Hashtag: #futuretx20
Recordings and Highlights
We thank all the speakers, participants, and attendees for sharing their ideas and expertise and for making the Symposium so successful. We have had two very rewarding days, filled with interesting sessions, demo presentations, as well as discussions around a wide range of machine learning methodology and new biotechnological platforms.
Videos from the presentations are now publicly available to everyone through the Symposium Video Channel. Archive Twitter Highlights are available too.
Our Speakers
Albert-László Barabási
Northeastern University
Harvard Medical School
Sergio Baranzini
UCSF
Regina Barzilay
MIT
Jan Baumbach
TU Munich
Andreas Bender
AstraZeneca
Cambridge University
Yoshua Bengio
University of Montreal
MILA
Michael Bronstein
Imperial College London
Anand Chokkalingam
Gilead Sciences
UC Berkeley
Djork-Arné Clevert
Bayer
James Collins
MIT
Broad Institute
Robert Gentleman
Harvard Medical School
Kevin Grimes
Stanford University
Bino John
AstraZeneca
Nevan Krogan
UCSF
Joseph Loscalzo
Harvard Medical School
Jure Leskovec
Stanford University
Chan Zuckerberg Biohub
Ziad Obermeyer
UC Berkeley
Marinka Zitnik
Harvard
Broad Institute
Vijay Pande
Andreessen Horowitz
Stanford University
Qi Liu
FDA
Therapeutics Data Commons
